| Literature DB >> 34956128 |
Feiyang Xie1, Wasu Pathom-Aree2.
Abstract
Deserts, as an unexplored extreme ecosystem, are known to harbor diverse actinobacteria with biotechnological potential. Both multidrug-resistant (MDR) pathogens and environmental issues have sharply raised the emerging demand for functional actinobacteria. From 2000 to 2021, 129 new species have been continuously reported from 35 deserts worldwide. The two largest numbers are of the members of the genera Streptomyces and Geodermatophilus, followed by other functional extremophilic strains such as alkaliphiles, halotolerant species, thermophiles, and psychrotolerant species. Improved isolation strategies for the recovery of culturable and unculturable desert actinobacteria are crucial for the exploration of their diversity and offer a better understanding of their survival mechanisms under extreme environmental stresses. The main bioprospecting processes involve isolation of target actinobacteria on selective media and incubation and selection of representatives from isolation plates for further investigations. Bioactive compounds obtained from desert actinobacteria are being continuously explored for their biotechnological potential, especially in medicine. To date, there are more than 50 novel compounds discovered from these gifted actinobacteria with potential antimicrobial activities, including anti-MDR pathogens and anti-inflammatory, antivirus, antifungal, antiallergic, antibacterial, antitumor, and cytotoxic activities. A range of plant growth-promoting abilities of the desert actinobacteria inspired great interest in their agricultural potential. In addition, several degradative, oxidative, and other functional enzymes from desert strains can be applied in the industry and the environment. This review aims to provide a comprehensive overview of desert environments as a remarkable source of diverse actinobacteria while such rich diversity offers an underexplored resource for biotechnological exploitations.Entities:
Keywords: actinobacteria; arid environment; bioactive compounds; cultivability; desert; diversity; natural products; plant growth promoting actinomycetes
Year: 2021 PMID: 34956128 PMCID: PMC8696123 DOI: 10.3389/fmicb.2021.765531
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
FIGURE 1Distribution of desert biomes.
List of new actinobacteria isolated from desert environment from 2000 to 2021.
| Order | Family | Genus | Species | References |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
| |
|
|
| |||
|
|
|
| ||
|
|
| |||
|
|
|
|
| |
|
| ||||
|
| ||||
|
|
| |||
|
|
|
|
| |
|
|
| |||
|
|
|
| ||
|
|
| |||
|
|
|
| ||
|
|
| |||
|
|
| |||
|
|
|
| ||
|
|
|
|
| |
|
|
| |||
|
| ||||
|
|
|
|
| |
|
|
|
|
| |
|
|
|
| ||
|
|
| |||
|
|
|
|
| |
|
|
| |||
|
|
| |||
|
|
| |||
|
|
| |||
|
|
| |||
|
|
| |||
|
|
| |||
|
|
| |||
|
|
| |||
|
|
| |||
|
|
| |||
|
|
| |||
|
|
| |||
|
|
| |||
|
|
| |||
|
|
|
|
| |
|
|
|
| ||
|
| ||||
|
| ||||
|
| ||||
|
|
| |||
|
|
|
| ||
|
|
| |||
|
|
|
|
| |
|
|
| |||
|
|
|
|
|
|
|
|
| |||
|
|
|
| ||
|
|
| |||
|
|
| |||
|
|
| |||
|
|
| |||
|
|
| |||
|
|
| |||
|
|
| |||
|
|
| |||
|
|
|
| ||
|
|
| |||
|
|
| |||
|
|
| |||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||
|
|
|
| ||
|
|
|
| ||
|
|
|
|
| |
|
|
|
| ||
|
| ||||
|
|
|
| ||
|
| ||||
|
|
| |||
|
|
| |||
|
|
| |||
|
|
|
| ||
|
|
|
| ||
|
|
|
|
| |
|
|
| |||
|
|
|
| ||
|
|
|
| ||
|
|
| |||
|
|
|
| ||
|
|
| |||
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
| ||
|
|
| |||
|
| ||||
|
|
| |||
|
|
|
|
|
|
|
| ||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
| ||
|
|
| |||
|
|
|
| ||
|
|
| |||
|
|
| |||
|
| ||||
|
| ||||
|
|
| |||
|
| ||||
|
|
| |||
|
|
|
| ||
|
| ||||
|
| ||||
|
|
|
| ||
|
|
| |||
|
|
|
| ||
|
|
| |||
|
|
| |||
|
|
|
| ||
|
|
|
| ||
|
|
|
| ||
|
|
| |||
|
|
| |||
|
|
| |||
|
|
| |||
|
|
| |||
|
|
| |||
|
|
|
| ||
|
|
*Species isolated from plants in desert area.
FIGURE 2Distribution of desert actinobacteria from different geographical regions: (A) East Asia, (B) Central Asia, (C) South Asia, (D) North Africa, (E) Middle East, and (F) South America.
FIGURE 3Percentage distribution of different orders of desert actinobacteria.
FIGURE 4Bioprospecting strategy for desert actinobacteria (modified from Goodfellow and Fiedler, 2010).
Comparison of serial dilution and sprinkling technique with number and relative abundance of actinobacterial colonies (cfus per gram of dry weight environmental samples) growing on selective media prior to incubation at 28°C for 14 days (modified from Xie, 2017).
| Selective medium | Serial dilution | Sprinkling | ||||
| Number of actinobacteria | Relative abundance (%, compared to the total bacteria) | Number of bioactive actinobacteria | Number of actinobacteria | Relative abundance (%, compared to the total bacteria) | Number of bioactive actinobacteria | |
|
| ||||||
| Gauze’s no. 1 agar + nalidixic acid (10 μg/ml) | 12 | 65 |
|
|
| 2 |
| Starch casein agar | 31 |
| 3 |
| 62 |
|
| HV agar | 5 | 50 | 0 |
|
|
|
|
| ||||||
| Gauze’s no. 1 agar + nalidixic acid (10 μg/ml) | 11 | 57 | 3 |
|
|
|
| Starch casein agar | 31 | 45 | 8 |
|
|
|
| HV agar | 1 | 29 | 0 |
|
|
|
|
| ||||||
| Gauze’s no. 1 agar + nalidixic acid (10 μg/ml) | 6 | 75 | 0 |
|
|
|
| Starch casein agar | 39 | 41 | 1 |
|
|
|
| HV agar | 5 | 5 | 0 |
|
|
|
|
| ||||||
| Gauze’s no. 1 agar + nalidixic acid (10 μg/ml) | 196 | 83 |
|
|
| 27 |
| Starch casein agar | 72 | 50 | 18 |
|
|
|
| HV agar | 63 | 43 |
|
|
| 12 |
The bolded number indicates the highest value in the comparison of serial dilution and sprinkling technique under the same column items. All media were supplemented with cycloheximide and nystatin (each at 25 μg/ml).
Novel natural products from desert actinobacteria between 2000 and 2021.
| Organisms | Location | Structure class | Compound | Bioactivity | References |
| Desert soil of Gansu, China | Pyrrol-2-aldehyde derivatives | Jiangrines A–E | Anti-inflammatory | ||
| Glycolipid | Jiangolide | ||||
| Indolizine derivative | Jiangrine F | Weak cytotoxicity | |||
| Atacama Desert, Chile | New diene and monoene glycosides | Lentzeosides A–F | Anti-HIV-1 integrase activity |
| |
| Xinjiang Desert, China | Ga-siderophores | Nocardimicins J–R | Virus polymerase inhibitory |
| |
| Benz[α]anthraquinones | Brasiliquinone E | Anti- | |||
| Saharan soil, Algeria | Butanoyl-pyrrothine (BUP) | Dithiolopyrrolone antibiotics | Antibacterial and antifungal activities | ||
| Senecioyl-pyrothine (SEP) | |||||
| Tigloyl-pyrrothine (TIP) | |||||
| Crotonyl-pyrrothine | Dithiolopyrrolone PR2 | Antibacterial, antifungal, and anti-yeast activities |
| ||
| Sorbyl-pyrrothine | Dithiolopyrrolone PR8 | ||||
| 2-Hexonyl-pyrrothine | Dithiolopyrrolone PR9 | ||||
| 2-Methyl-3-pentenyl-pyrrothine | Dithiolopyrrolone PR10 | ||||
| Iso-hexanoyl-pyrrothine | Dithiolopyrrolone PR11 |
| |||
| C29H30O8 | Antibiotic A4 | Antifungal and antibacterial activities |
| ||
| C30H32O8 | Antibiotic A5 | ||||
| Atacama Desert, Chile | β-Diketones | Asenjonamides A–C | Antibacterial activity |
| |
| New 22-membered macrolactone polyketides | Chaxalactins A–C | Antibacterial activity |
| ||
| New ansamycin-type polyketides | Chaxamycins A–C | Anti-intrinsic ATPase activity of heat shock protein 90 (Hsp), anti-methicillin-resistant |
| ||
| Chaxamycin D | |||||
| Novel lasso peptide | Leepeptin | ND |
| ||
| New family of 22-membered antitumor macrolactones | Atacamycins A-C | Antibacterial, antitumor, and cytotoxic activities |
| ||
| New lasso peptide | Chaxapeptin | Anti-human lung cancer cell line A549 |
| ||
| Taklamakan Desert, China | New streptogramin-type antibiotics | Acetyl-griseoviridin | No antibacterial activity |
| |
| Desulfurizing griseoviridin | Antibacterial activity | ||||
| Saudi Arabian desert | New pyridine alkaloid | Pyridine alkaloid: pyridine-2,5-diacetamide | Antimicrobial activity |
| |
| Atacama Desert, Chile | Aminoquinone derivatives | Abenquines A–D | Antibacterial, anti-dermatophytic fungal, and anti-phosphodiesterase type 4b activities |
| |
| Thar Desert, Rajasthan (India) | New anthracyclines | Non-named | Anticancer activity |
| |
| New anthracycline glycoside | Antibacterial activity | ||||
| New macrolide | |||||
| New anthracycline glycoside | |||||
| New macrolide | |||||
| New macrolide | |||||
Agricultural applications from desert actinobacteria between 2000 and 2021.
| Organism | Location | PGP traits | Target | References |
| Atacama Desert, Chile | Siderophore production, auxin (AIA) production, nitrogen fixation, ACC deaminase activity and phosphate solubilization | ND |
| |
| Saudi Arabia, Jizan and AI Wahbah | Chitinase activity | Pathogens |
| |
| β-Glucosidases | Degradation of cellulose biopolymers | |||
| Osmoprotectants | Oxidative, osmotic, and salinity stresses | |||
| Volatiles: hydrogen sulfide | Biotic and abiotic stress | |||
| Saline desert of Little Rann of Kutch, Gujarat, India | IAA | Groundnut ( |
| |
| The rhizosphere of desert plant | Plant growth-promoting activity | Maize |
| |
| Sahara, Algeria | Biocontrol activity | Common root rot pathogen caused by |
| |
| IAA, siderophore, hydrogen cyanide, chitinolytic activity, and solubilized inorganic phosphates | Durum wheat (cv. Vitron) | |||
| Saharan, Algeria | Biocontrol activity | Temperate crop |
| |
| IAA and GA3 | Soft wheat ( | |||
| Baja California, Mexico | Antifungal activity |
| ||
| Inorganic phosphate solubilization | ND | |||
| IAA, GA | Tomato ( | |||
| Saudi Arabia, Jouf | Flavonoid, phytohormone, and siderophore production | Maize ( |
| |
| Monte Desert, NW of Patagonia, Neuquén | Auxin, cytokines, zeatins, and siderophores | ND |
| |
| Exoenzymes: proteases, phospholipase, and lipases | ||||
| Phosphorous solubilization | Native vegetation | |||
| Merzouga, Morocco | IAA, siderophore production, N2 fixation, P and K solubilization | ND |
| |
| The Algerian Sahara | Crude IAA | Tomato |
| |
| Salt Lake Qom, Iran | IAA, ethylene via ACC deaminase, and siderophores | Sunflower |
| |
| Sinai Desert, Egypt | Antifungal |
| ||
| Antibacterial |
| |||
| Antinematicidal |
ND, not determined.